Showing results (791-800 of 929) with videos related to

Sort By:
Pageof 93
Journal of Psychopharmacology (Oxford, England)|March 30, 2013
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studiesEmiliangelo Ratti, Paolo Bettica, Robert Alexander, et al.
Plos One|May 17, 2019
Whole blood transcriptomic profiles can differentiate vulnerability to chronic low back painSusan G Dorsey, Cynthia L Renn, Mari Griffioen, et al.
Pain Reports|July 8, 2026
Development of a core outcome set for clinical trials of extended reality for painGiulia Mesaroli, Courtney W Hess, Fahad Alam, et al.
The Journal of Clinical Psychiatry|August 28, 2009
A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorderDavid Mischoulon, George I Papakostas, Christina M Dording, et al.
Psychiatry Investigation|December 3, 2016
Gender Differences in Somatic Symptoms and Current Suicidal Risk in Outpatients with Major Depressive DisorderHong Jin Jeon, Jong-Min Woo, Hyo-Jin Kim, et al.
Biological Psychiatry|December 17, 2021
Patterns of Pretreatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results From the EMBARC Randomized Clinical TrialKevin P Nguyen, Cherise Chin Fatt, Alex Treacher, et al.
The American Journal of Psychiatry|September 28, 2007
Effect of age at onset on the course of major depressive disorderSidney Zisook, Ira Lesser, Jonathan W Stewart, et al.
BMJ Open|June 24, 2019
Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatmentAnnabelle M Belcher, Thomas O Cole, Aaron D Greenblatt, et al.
The American Journal of Psychiatry|July 4, 2006
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D reportMaurizio Fava, A John Rush, Stephen R Wisniewski, et al.
American Journal of Human Genetics|April 28, 2006
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatmentFrancis J McMahon, Silvia Buervenich, Dennis Charney, et al.
Pageof 93